Search Results - "MIODINI, Patrizia"
-
1
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression
Published in International journal of molecular sciences (21-02-2020)“…Circulating tumor cells (CTCs) are promising biomarkers for prognosis, therapeutic response prediction, and treatment monitoring in cancer patients. Despite…”
Get full text
Journal Article -
2
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study)
Published in Therapeutic advances in medical oncology (01-01-2024)“…Up to 30% of patients with metastatic castration-resistant prostate cancer (mCRPC) develop visceral metastases, which are associated with a poor prognosis…”
Get full text
Journal Article -
3
Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer
Published in International journal of molecular sciences (09-01-2018)“…Metachronous (MBC) and synchronous bilateral breast tumors (SBC) are mostly distinct primaries, whereas paired primaries and their local recurrences (LRC)…”
Get full text
Journal Article -
4
Use of formalin-fixed paraffin-embedded samples for gene expression studies in breast cancer patients
Published in PloS one (06-04-2015)“…To obtain gene expression profiles from samples collected in clinical trials, we conducted a pilot study to assess feasibility and estimate sample attrition…”
Get full text
Journal Article -
5
Prospective evaluation of estrogen receptor-β in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients
Published in Endocrine-related cancer (01-12-2004)“…It has been proposed that knowledge of estrogen receptor β (ER-β) expression may refine estrogen receptor α (ER-α) predictivity of response to endocrine…”
Get full text
Journal Article -
6
Metabolic Footprints and Molecular Subtypes in Breast Cancer
Published in Disease markers (01-01-2017)“…Cancer treatment options are increasing. However, even among the same tumor histotype, interpatient tumor heterogeneity should be considered for best…”
Get full text
Journal Article -
7
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma
Published in Clinical chemistry (Baltimore, Md.) (18-05-2022)“…Abstract Background The isolation of circulating tumor cells (CTCs) requires rapid processing of the collected blood due to their inherent fragility. The…”
Get full text
Journal Article -
8
A phase II study evaluating the efficacy of enzalutamide and the role of ARv7 in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) with visceral disease
Published in Journal of clinical oncology (20-05-2021)“…Abstract only 5052 Background: Enzalutamide is a second-generation androgen receptor inhibitor that showed to prolong survival in different setting of prostate…”
Get full text
Journal Article -
9
Abstract 1747: A microenvironment gene signature predicts poor outcome in patients with luminal breast cancers subjected to local-regional treatment
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Gene expression studies, mainly addressed at the tumor cell compartment of breast cancers (BC) contributed to unravel the molecular heterogeneity…”
Get full text
Journal Article -
10
Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer
Published in Breast cancer research and treatment (01-06-2011)“…Male breast cancer (MBC) is a poorly characterized disease because of its rarity. Clinical management is based on results obtained from randomized trials…”
Get full text
Journal Article -
11
Abstract 1390: Molecular characterization of circulating tumor cells in cholangiocarcinoma patients: A new tool for treatment management
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract BACKGROUND: Cholangiocarcinoma (CCA) is a highly fatal disease mainly treated with standard chemotherapy, albeit with limited efficacy. New…”
Get full text
Journal Article -
12
Prognostic and functional role of subtype‐specific tumor–stroma interaction in breast cancer
Published in Molecular oncology (01-10-2017)“…None of the clinically relevant gene expression signatures available for breast cancer were specifically developed to capture the influence of the…”
Get full text
Journal Article -
13
Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience
Published in Cancers (13-07-2019)“…Enzalutamide and abiraterone have been shown to improve progression-free survival (PFS) and overall survival (OS) in metastatic castration-resistant prostate…”
Get full text
Journal Article -
14
Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer
Published in Molecular oncology (01-10-2014)“…The majority of gene expression signatures developed to predict the likelihood to relapse in breast cancer (BC) patients assigns a high risk score to patients…”
Get full text
Journal Article -
15
Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors
Published in Advances in experimental medicine and biology (01-01-2017)“…Genomic characterization of circulating tumor cells (CTCs) enables the monitoring of tumor progression and of adaption occurring during treatment. CTC…”
Get more information
Journal Article -
16
Applicability of Under Vacuum Fresh Tissue Sealing and Cooling to Omics Analysis of Tumor Tissues
Published in Biopreservation and biobanking (01-12-2016)“…Biobanks of frozen human normal and malignant tissues represent a valuable source for "omics" analysis in translational cancer research and molecular…”
Get more information
Journal Article -
17
Proliferation-, estrogen-, and T-cell-related metagenes to predict outcome after adjuvant/neoadjuvant chemotherapy for operable breast cancer in the ECTO trial
Published in Journal of clinical oncology (20-05-2013)“…Abstract only 1014 Background: Predicting recurrence in operable breast cancer (BC) despite optimal chemotherapy would be relevant to new drug development and…”
Get full text
Journal Article -
18
Clusterin : A potential target for improving response to antiestrogens
Published in International journal of oncology (01-10-2008)“…Antiestrogens represent the first line of therapy in the treatment of estrogen receptor-positive (ER+) breast cancer patients. Unfortunately, up to 40% of…”
Get full text
Journal Article -
19
Modulation of estrogen receptor-β isoforms by phytoestrogens in breast cancer cells
Published in International journal of oncology (01-05-2006)“…High consumption of phytoestrogen-rich food correlates with reduced incidence of breast cancer. However, the effect of phytoestrogens on growth of pre-existing…”
Get full text
Journal Article -
20
Use of Formalin-Fixed Paraffin-Embedded Samples for Gene Expression Studies in Breast Cancer Patients: e0123194
Published in PloS one (01-04-2015)“…To obtain gene expression profiles from samples collected in clinical trials, we conducted a pilot study to assess feasibility and estimate sample attrition…”
Get full text
Journal Article